2012
January 1st
Luxury residential tower in Dubai Marina.
2019
June 28th
Investment in Fund
October 8th
A Swiss clinical-stage biotechnology company with an encapsulated cellular cancer immunotherapy.
2020
July 14th
Medical curved implants for curved bones within the body.
September 15th
Orthopaedic surgery instrumentation.
September 25th
Investment in Fund
October 28th
A neuromodulation company based in the USA.
2021
January 11th
A next-generation asset management company.
January 15th
Investment in Fund
January 18th
Investment in Series BB Prefered Stock
April 29th
Orthopaedic surgery instrumentation.
June 1st
Second tranche investment.
June 13th
Investment in shares.
June 21st
Participation in the second closing of Series B-1 shares.
September 27th
New capital contribution.
2022
January 16th
Participation in the milestone closing of Series B-1 shares.
February 1st
Participating in NEMO V with Garuda Therapeutics and Magnolia Medical Technologies.
February 28th
A neuromodulation company based in the USA.
April 6th
Participating in NEMO V with Garuda Therapeutics and Magnolia Medical Technologies.
September 28th
Investment in Capital Call 3
December 11th
A neuromodulation company based in the USA.
2023
January 15th
Investment in Capital Call 4
February 9th
Investment in Convertible Loan
March 15th
Investment in Capital Call Cash Less
March 23rd
Investment in Capital Call 5
May 22nd
Investment in Convertible Loan
July 12th
Investment in Series C Preferred Stock
July 18th
Investment in Capital Call 6
September 11th
Investment in shares.
November 21st
Investment in Capital Call 7
2024
January 28th
Investment in C1 Preffered Stock
January 28th
Investment in C2 Shares
May 3rd
Investment in shares.
May 3rd
Investment of Convertible Loan
June 20th
Investment in Capital Call 8
November 14th
Investment in C1 Shares
2025
April 2nd
Investment in Capital Call 9
June 30th
Invetment in Series D Preferred Shares
September 2nd
Investment in shares.
